LPL Financial LLC acquired a new stake in shares of Ampio Pharmaceuticals, Inc. (NYSEAMERICAN:AMPE) during the fourth quarter, HoldingsChannel.com reports. The fund acquired 28,200 shares of the specialty pharmaceutical company’s stock, valued at approximately $115,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Creative Planning acquired a new stake in Ampio Pharmaceuticals in the fourth quarter valued at approximately $116,000. Raymond James & Associates acquired a new stake in Ampio Pharmaceuticals in the fourth quarter valued at approximately $137,000. Wells Fargo & Company MN boosted its stake in Ampio Pharmaceuticals by 113.7% in the fourth quarter. Wells Fargo & Company MN now owns 40,671 shares of the specialty pharmaceutical company’s stock valued at $166,000 after acquiring an additional 21,638 shares in the last quarter. Brandes Investment Partners LP acquired a new stake in Ampio Pharmaceuticals in the fourth quarter valued at approximately $204,000. Finally, Virtu Financial LLC boosted its stake in Ampio Pharmaceuticals by 787.5% in the fourth quarter. Virtu Financial LLC now owns 92,344 shares of the specialty pharmaceutical company’s stock valued at $376,000 after acquiring an additional 81,939 shares in the last quarter.

Shares of AMPE opened at $2.89 on Friday. Ampio Pharmaceuticals, Inc. has a twelve month low of $0.38 and a twelve month high of $4.95.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a development stage biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process; and decreasing vascular permeability.

Want to see what other hedge funds are holding AMPE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ampio Pharmaceuticals, Inc. (NYSEAMERICAN:AMPE).

Institutional Ownership by Quarter for Ampio Pharmaceuticals (NYSEAMERICAN:AMPE)

Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.